MUMBAI, India, Sept. 14 -- Intellectual Property India has published a patent application (202641103926 A) filed by Christ University on August 28, 2026, for Novel Anti Diabetic Drug Candidates And An Integrated In Silico And In Vitro Workflow.
Inventors include Anish Nag; Anna Atheena Antony; Serlin Phukan; Avijit Kumar; and Hazeena Shinziya.
The application for the patent was published on September 11, 2026, under issue no. 37/2026.
Abstract: Three novel anti-diabetic drugs, namely, 2-hydroxy-1-naphthaldehyde (HNPD), 3,6-diamino acridine hydrochloride (AHCL), and 4-oxo-4H-benzo[h]chromene-3- carbaldehyde (BCC), were evaluated to understand their inhibition properties against the diabetic enzymes (alpha-glucosidase and alpha-amylase) us...